Evidence map›Paper›PMID 33801692›Full record

ArticlePharmaceutics2021

Synergistic Effect of Growth Factor Releasing Polymeric Nanoparticles and Ultrasound Stimulation on Osteogenic Differentiation.

Minki Jin, Bo Seok Kim, Sung Ho Seo, Minjeong Kim, Yun Gyeong Kang, Jung-Woog Shin, Kwan Hyung Cho, Meong Cheol Shin, Changhan Yoon, Kyoung Ah Min

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Minki JinCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Bo Seok KimDepartment of Nanoscience and Engineering, School of Biomedical Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Sung Ho SeoDepartment of Nanoscience and Engineering, School of Biomedical Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Minjeong KimDepartment of Biomedical Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Yun Gyeong KangDepartment of Biomedical Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.ORCID 0000-0002-1882-0854
Jung-Woog ShinDepartment of Biomedical Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Kwan Hyung ChoCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Meong Cheol ShinCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, 501 Jinju Daero, Jinju, Gyeongnam 52828, Korea.
Changhan YoonDepartment of Nanoscience and Engineering, School of Biomedical Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Kyoung Ah MinCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Korea.
Inje University · KRGyeongsang National University · KR

Funding

Inje University 2017 Inje University research grant
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have been extensively used in the tissue regeneration therapy. Ex vivo therapy with well-differentiated osteogenic cells is known as an efficient treatment for musculoskeletal diseases, including rheumatoid diseases. However, along with its high cost, the current therapy has limitations in terms of restoring bone regeneration procedures. An efficient process for the cell differentiation to obtain a large number of functionalized osteogenic cells is necessary. Therefore, it is strongly recommended to develop strategies to produce sufficient numbers of well-differentiated osteogenic cells from the MSCs. In general, differentiation media with growth factors have been used to facilitate cell differentiation. In the present study, the poly (lactic-co-glycolic acid) (PLGA) nanoparticles incorporating the growth factors were included in the media, resulting in releasing growth factors (dexamethasone and β-glycerophosphate) in the media in the controlled manner. Stable growth and early differentiation of osteogenic cells were achieved by the PLGA-based growth factor releasing system. Moreover, low intensity pulsed ultrasound was applied to this system to induce cell differentiation process. The results revealed that, as a biomarker at early stage of osteogenic cell differentiation, Lamin A/C nuclear protein was efficiently expressed in the cells growing in the presence of PLGA-based growth factor reservoirs and ultrasound. In conclusion, our results showed that the ultrasound stimulation combined with polymeric nanoparticles releasing growth factors could potentially induce osteogenic cell differentiation.

Indexed as

lamin A/Clow-intensity pulsed ultrasoundmesenchymal stem cellsosteogenic differentiationpoly (lactic-co-glycolic acid) nanoparticles

Identifiers

PMID33801692
PMCPMC8066944
OpenAlexW3143134898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.